Login
$REPL
$21.32 -$0.09 (0.42%) After hours

Company Executives

Officer Age In this role 2026 pay Source
Sushil Patel Also a director
Chief Executive Officer
55 Not stated $5,845,982
Emily Hill
Chief Financial Officer
46 Since 2023
3 years
$2,092,571
Konstantinos Xynos
Chief Medical Officer
60 Since 2022
4 years
$2,112,781
Andrew Schwendenman
Chief Accounting Officer
Title from the Form 4 dated Aug 10, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
10
serving now
Independent
8 of 10
stated in the proxy
Average tenure
5.6 years
from year joined
CEO also chairs the board
No
Philip Astley-Sparke
Director On board Independent Committees Other public boards 2026 pay Source
Philip Astley-Sparke
2015
11 years
Not independent None stated enGene Therapeutics Inc. Not stated
Sushil Patel
2024
2 years
Not independent None stated Revolution Medicines, Inc. Paid as CEO
Dieter Weinand
2018
8 years
Independent
Nominating and Corporate Governance Committee · Chair Audit Committee
Coya Therapeutics, Evotec SE $278,608
Madhavan Balachandran
2024
2 years
Independent None stated uniQure, N.V., Stevanato Group S.p.A $231,108
Kapil Dhingra
2017
9 years
Independent
Compensation Committee Research & Development Committee · Chair
Black Diamond Therapeutics, Inc. $246,108
Michael Goller
2025
1 year
Independent
Nominating and Corporate Governance Committee
DBV Technologies S.A. $50,000
Christy Oliger
2021
5 years
Independent
Compensation Committee · Chair Research & Development Committee
Karyopharm Therapeutics Inc., Vera Therapeutics, Inc. $246,108
Joseph Slattery
2017
9 years
Independent
Compensation Committee Audit Committee · Chair
None stated $251,108
Veleka R. Peeples-Dyer Leaving at the meeting
2023
3 years
Independent
Nominating and Corporate Governance Committee Audit Committee
None stated $238,608
Paolo Pucci Leaving at the meeting
2020
6 years
Independent
Nominating and Corporate Governance Committee Research & Development Committee
West Pharmaceuticals Services, Inc. $236,108

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Jul 29, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support